De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma. 2022

Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA 02215, USA; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Mutations affecting isocitrate dehydrogenase (IDH) enzymes are prevalent in glioma, leukemia, and other cancers. Although mutant IDH inhibitors are effective against leukemia, they seem to be less active in aggressive glioma, underscoring the need for alternative treatment strategies. Through a chemical synthetic lethality screen, we discovered that IDH1-mutant glioma cells are hypersensitive to drugs targeting enzymes in the de novo pyrimidine nucleotide synthesis pathway, including dihydroorotate dehydrogenase (DHODH). We developed a genetically engineered mouse model of mutant IDH1-driven astrocytoma and used it and multiple patient-derived models to show that the brain-penetrant DHODH inhibitor BAY 2402234 displays monotherapy efficacy against IDH-mutant gliomas. Mechanistically, this reflects an obligate dependence of glioma cells on the de novo pyrimidine synthesis pathway and mutant IDH's ability to sensitize to DNA damage upon nucleotide pool imbalance. Our work outlines a tumor-selective, biomarker-guided therapeutic strategy that is poised for clinical translation.

UI MeSH Term Description Entries
D007521 Isocitrate Dehydrogenase An enzyme of the oxidoreductase class that catalyzes the conversion of isocitrate and NAD+ to yield 2-ketoglutarate, carbon dioxide, and NADH. It occurs in cell mitochondria. The enzyme requires Mg2+, Mn2+; it is activated by ADP, citrate, and Ca2+, and inhibited by NADH, NADPH, and ATP. The reaction is the key rate-limiting step of the citric acid (tricarboxylic) cycle. (From Dorland, 27th ed) (The NADP+ enzyme is EC 1.1.1.42.) EC 1.1.1.41. NAD Isocitrate Dehydrogenase,Isocitrate Dehydrogenase (NAD+),Isocitrate Dehydrogenase-I,Dehydrogenase, Isocitrate,Dehydrogenase, NAD Isocitrate,Isocitrate Dehydrogenase I,Isocitrate Dehydrogenase, NAD
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012458 Salicylanilides 2-Hydroxy-N-phenylbenzamides. N-phenyl substituted salicylamides. Derivatives have been used as fungicides, anti-mildew agents and topical antifungal agents. In concentrated form may cause irritation of skin and mucous membranes. N-Phenylsalicylamides,N Phenylsalicylamides
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
December 2022, Cancer cell,
Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
April 2017, Cancer discovery,
Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
July 2017, Cancer discovery,
Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
January 2024, Heliyon,
Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
January 2011, Journal of the American Chemical Society,
Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
January 2022, Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko,
Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
October 2022, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
September 2022, Proceedings of the National Academy of Sciences of the United States of America,
Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
September 2022, Cancer cell,
Diana D Shi, and Milan R Savani, and Michael M Levitt, and Adam C Wang, and Jennifer E Endress, and Cylaina E Bird, and Joseph Buehler, and Sylwia A Stopka, and Michael S Regan, and Yu-Fen Lin, and Vinesh T Puliyappadamba, and Wenhua Gao, and Januka Khanal, and Laura Evans, and Joyce H Lee, and Lei Guo, and Yi Xiao, and Min Xu, and Bofu Huang, and Rebecca B Jennings, and Dennis M Bonal, and Misty S Martin-Sandoval, and Tammie Dang, and Lauren C Gattie, and Amy B Cameron, and Sungwoo Lee, and John M Asara, and Harley I Kornblum, and Tak W Mak, and Ryan E Looper, and Quang-De Nguyen, and Sabina Signoretti, and Stefan Gradl, and Andreas Sutter, and Michael Jeffers, and Andreas Janzer, and Mark A Lehrman, and Lauren G Zacharias, and Thomas P Mathews, and Julie-Aurore Losman, and Timothy E Richardson, and Daniel P Cahill, and Ralph J DeBerardinis, and Keith L Ligon, and Lin Xu, and Peter Ly, and Nathalie Y R Agar, and Kalil G Abdullah, and Isaac S Harris, and William G Kaelin, and Samuel K McBrayer
May 2021, Nature reviews. Drug discovery,
Copied contents to your clipboard!